NCT06308172

Brief Summary

The objective of this randomized monocentric study is to assess potential variations in the incidence and severity of isthmocele morbidity among women undergoing cesarean section with either single or double-layer closure of the hysterotomy. Our primary outcome aims to investigate whether there is a reduction in the median duration of intermenstrual spotting in patients belonging to the two respective closure groups

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Dec 2021Dec 2026

Study Start

First participant enrolled

December 1, 2021

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

March 6, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 13, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

March 13, 2024

Status Verified

March 1, 2023

Enrollment Period

3 years

First QC Date

March 6, 2024

Last Update Submit

March 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intermenstrual bleeding reduction (days)

    The primary outcome of the study is to evaluate weather there is a reduction of intermenstrual bleeding in the six months after cesarean section among the two groups of patients.

    6 months

Secondary Outcomes (6)

  • Intra-operatory time

    6 months

  • Blood loss

    6 months

  • Analgesics

    6 months

  • Post-operatory recovery time

    6 months

  • Time to full patient mobilization

    6 months

  • +1 more secondary outcomes

Study Arms (2)

Single-layer

EXPERIMENTAL

Patients who are randomized in this arm undergo a single layer-hysterotomy closure

Procedure: Hysterotomy closure

Double-layer

EXPERIMENTAL

Patients who are randomized in this arm undergo a double layer-hysterotomy closure

Procedure: Hysterotomy closure

Interventions

Hysterotomy closure is done in either one of two ways. Single layer closure consists in a single layer, unlocked suture. Double layer closure consists in a double layer, unlocked suture.

Double-layerSingle-layer

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • nulliparous
  • singleton
  • age 18-45
  • spontaneous pregnancy or autologous assisted fertilization
  • gestational age 38-40 weeks
  • elective C-section
  • informed consent

You may not qualify if:

  • coagulopathy
  • autoimmune diseases
  • gestational diabetes
  • anticoagulant therapy
  • immunosuppressive therapy
  • endometriosis
  • uterine fibromatosis
  • spontaneous labour
  • connective tissue diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Cà Granda IRCCS Ospedale Maggiore Policlinico di Milano

Milan, Mi, 20122, Italy

RECRUITING

Related Publications (6)

  • Hegde CV. The never ending debate single-layer versus double-layer closure of the uterine incision at cesarean section. J Obstet Gynaecol India. 2014 Aug;64(4):239-40. doi: 10.1007/s13224-014-0573-9. Epub 2014 Jul 23. No abstract available.

    PMID: 25136167BACKGROUND
  • Qayum K, Kar I, Sofi J, Panneerselvam H. Single- Versus Double-Layer Uterine Closure After Cesarean Section Delivery: A Systematic Review and Meta-Analysis. Cureus. 2021 Sep 30;13(9):e18405. doi: 10.7759/cureus.18405. eCollection 2021 Sep.

  • Marchand GJ, Masoud A, King A, Ruther S, Brazil G, Ulibarri H, Parise J, Arroyo A, Coriell C, Goetz S, Christensen A, Sainz K. Effect of single- and double-layer cesarean section closure on residual myometrial thickness and isthmocele - a systematic review and meta-analysis. Turk J Obstet Gynecol. 2021 Dec 24;18(4):322-332. doi: 10.4274/tjod.galenos.2021.71173.

  • Verberkt C, Stegwee SI, Van der Voet LF, Van Baal WM, Kapiteijn K, Geomini PMAJ, Van Eekelen R, de Groot CJM, de Leeuw RA, Huirne JAF; 2Close study group. Single-layer vs double-layer uterine closure during cesarean delivery: 3-year follow-up of a randomized controlled trial (2Close study). Am J Obstet Gynecol. 2024 Sep;231(3):346.e1-346.e11. doi: 10.1016/j.ajog.2023.12.032. Epub 2023 Dec 26.

  • Budny-Winska J, Zimmer-Stelmach A, Pomorski M. Impact of selected risk factors on uterine healing after cesarean section in women with single-layer uterine closure: A prospective study using two- and three-dimensional transvaginal ultrasonography. Adv Clin Exp Med. 2022 Jan;31(1):41-48. doi: 10.17219/acem/142519.

  • Di Spiezio Sardo A, Saccone G, McCurdy R, Bujold E, Bifulco G, Berghella V. Risk of Cesarean scar defect following single- vs double-layer uterine closure: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2017 Nov;50(5):578-583. doi: 10.1002/uog.17401. Epub 2017 Oct 9.

MeSH Terms

Conditions

Uterine HemorrhageCicatrixUterine Anomalies

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsFibrosis

Study Officials

  • Giuseppe Perugino, MD

    Ospedale Policlinico Maggiore Ca' Granda Milano

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Patients are recruited and randomly assigned to either the "single-layer" or "double-layer" arm of the study. The randomization process occurs on the day of the cesarean section. Following randomization, patients are informed about their assigned group, and the cesarean section procedure is then carried out.
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 13, 2024

Study Start

December 1, 2021

Primary Completion

December 1, 2024

Study Completion (Estimated)

December 1, 2026

Last Updated

March 13, 2024

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in cesarean section outcomes. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available by may 2025
Access Criteria
Data will be shared upon reasonable request

Locations